Table of Contents
Journal of Biomarkers
Volume 2013 (2013), Article ID 812170, 8 pages
http://dx.doi.org/10.1155/2013/812170
Research Article

T-Cell Response to Hepatitis B Core Antigen: Identification of Prior Exposure to and Confirmatory Testing for Screening for Anti-HBc

1Infection Diseases Laboratory, Colsan/UNIFESP, Avenida Indianópolis, 1260 Indianópolis, São Paulo, SP, Brazil
2American Red Cross, USA
3Colsan, Technical and Research Department, Brazil
4Colsan, Quality Laboratory, Brazil
5Retrovirology Laboratory, UNIFESP, Brazil
6Colsan, Associação Beneficente de Coleta de Sangue, Head Colsan, Brazil

Received 18 June 2013; Revised 8 September 2013; Accepted 8 September 2013

Academic Editor: Rajarshi Pal

Copyright © 2013 Patricia Araujo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Idrees, S. Khan, and S. Riazuddin, “Common genotypes of hepatitis B virus,” Journal of the College of Physicians and Surgeons Pakistan, vol. 14, no. 6, pp. 344–347, 2004. View at Google Scholar · View at Scopus
  2. C. Liu, D. Chen, and P. Chen, “Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT,” Journal of Clinical Virology, vol. 36, supplement 1, pp. S33–S44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Li, W. Li, F. Guo et al., “A novel real-time PCR assay for determination of viral loads in person infected with hepatitis B virus,” Journal of Virological Methods, vol. 165, pp. 9–14, 2010. View at Google Scholar
  4. D. Paraskevis, C. Haida, N. Tassopoulos et al., “Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA,” Journal of Virological Methods, vol. 103, no. 2, pp. 201–212, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-P. Allain, “Occult hepatitis B virus infection: implications in transfusion,” Vox Sanguinis, vol. 86, no. 2, pp. 83–91, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Raimondo, J. Allain, M. R. Brunetto et al., “Statements from the Taormina expert meeting on occult hepatitis B virus infection,” Journal of Hepatology, vol. 49, no. 4, pp. 652–657, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Zou, S. L. Stramer, and R. Y. Dodd, “Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations,” Transfusion Medicine Reviews, vol. 26, no. 2, pp. 119–128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. J. Mendes-Corrêa, A. A. Barone, N. D. P. Cavalheiro, F. M. Tengano, and C. Guastini, “Prevalence of hepatitis B and C in the sera of patients with HIV infection in São Paulo, Brazil,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 42, no. 2, pp. 81–85, 2000. View at Google Scholar · View at Scopus
  9. L. H. S. Oliveira, I. R. Silva, B. L. S. Xavier, and S. M. B. Cavalcanti, “Hepatitis B infection among patients attending a sexually transmitted diseases clinic in Rio de Janeiro, Brazil,” Memorias do Instituto Oswaldo Cruz, vol. 96, no. 5, pp. 635–640, 2001. View at Google Scholar · View at Scopus
  10. M. R. D. Monteiro, M. M. do Nascimeeto, A. D. Passos, and J. F. Figueiredo, “Soroepidemiological survey of hepatitis B virus among HIV/AIDS patients in Belém, Pará—Brasil,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 37, no. 2, pp. 27–32, 2004. View at Google Scholar · View at Scopus
  11. C. V. Tovo, D. E. dos Santos, Â. Z. de Mattos, P. R. L. de Almeida, A. A. de Mattos, and B. R. Santos, “Ambulatorial prevalence of hepatitis B and C markers in patients with human immunodeficiency virus infection in a general hospital,” Arquivos de Gastroenterologia, vol. 43, no. 2, pp. 73–76, 2006. View at Google Scholar · View at Scopus
  12. A. M. Zago, T. F. Machado, F. L. Cazarim, and A. E. Miranda, “Prevalence and risk factors for chronic hepatitis B in HIV patients attended at a sexually-transmitted disease clinic in Vitoria, Brazil,” Brazilian Journal of Infectious Diseases, vol. 11, no. 5, pp. 475–478, 2007. View at Google Scholar · View at Scopus
  13. A. M. P. Filho, C. U. do Nascimento, T. N. Tannouri et al., “Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil,” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 7, pp. 960–963, 2009. View at Google Scholar · View at Scopus
  14. C. Maresch, P. J. Schluter, A. D. Wilson, and A. Sleigh, “Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil,” Transfusion, vol. 48, no. 2, pp. 273–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. P. R. B. Araujo, “Estimates of residual pathogen transmission risk in São Paulo,” in Proceedings of the Congress Brazilian Hematology and Hemoterapy, Florianópolis, Brazil, 2010.
  16. C. Niederhauser, P. Schneider, M. Fopp, A. Ruefer, and G. Lévy, “Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003,” Euro Surveillance, vol. 10, no. 2, pp. 14–16, 2005. View at Google Scholar · View at Scopus
  17. R. Sitnik, Â. Paes, C. P. Mangueira, and J. R. R. Pinho, “A real-time quantitative assay for hepatitis B DNA virus (HBV) developed to detect all HBV genotypes,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 52, no. 3, pp. 119–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Zou, F. Musavi, E. P. Notari, S. L. Stramer, and R. Y. Dodd, “Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008,” Transfusion, vol. 50, no. 7, pp. 1487–1494, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. R. Seed, P. Kiely, and A. J. Keller, “Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus,” Internal Medicine Journal, vol. 35, no. 10, pp. 592–598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Otsubo and K. Yamaguchi, “Current risks in blood transfusion in Japan,” Japanese Journal of Infectious Diseases, vol. 61, no. 6, pp. 427–433, 2008. View at Google Scholar · View at Scopus
  21. H. Yotsuyanagi, K. Yasuda, K. Moriya et al., “Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors,” Transfusion, vol. 41, no. 9, pp. 1093–1099, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Bes, V. Vargas, M. Piron et al., “T cell responses and viral variability in blood donation candidates with occult hepatitis B infection,” Journal of Hepatology, vol. 56, no. 4, pp. 765–774, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Rehermann, P. Fowler, J. Sidney et al., “The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis,” Journal of Experimental Medicine, vol. 181, no. 3, pp. 1047–1058, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Liaw and C. Chu, “Hepatitis B virus infection,” The Lancet, vol. 373, no. 9663, pp. 582–592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Penna, M. Artini, A. Cavalli et al., “Long-lasting memory T cell responses following self-limited acute hepatitis B,” Journal of Clinical Investigation, vol. 98, no. 5, pp. 1185–1194, 1996. View at Google Scholar · View at Scopus
  26. R. Thimme, S. Wieland, C. Steiger et al., “CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection,” Journal of Virology, vol. 77, no. 1, pp. 68–76, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Ferrari, A. Penna, A. Bertoletti et al., “Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection,” Journal of Immunology, vol. 145, no. 10, pp. 3442–3449, 1990. View at Google Scholar · View at Scopus
  28. A. Zerbini, M. Pilli, C. Boni et al., “The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection,” Gastroenterology, vol. 134, pp. 1470–1481, 2008. View at Google Scholar
  29. S. L. Stramer, U. Wend, D. Candotti et al., “Nucleic acid testing to detect HBV infection in blood donors,” The New England Journal of Medicine, vol. 364, no. 3, pp. 236–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. L. Stramer, S. Zou, E. P. Notari et al., “Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?” Transfusion, vol. 52, no. 2, pp. 440–446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C. M. D. Silva, C. Costi, C. Costa et al., “Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil,” Journal of Infection, vol. 51, no. 1, pp. 24–29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Candotti, P. Grabarczyk, P. Ghiazza et al., “Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains,” Journal of Hepatology, vol. 49, no. 4, pp. 537–547, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Kiesslich, N. A. Fraiji, M. A. Crispim et al., “Prevalence of serologic and molecular markers of hepatitis B virus infection among pregnant women in Amazonas State, Brazil,” Epidemiologia e Services de Saúde, vol. 12, no. 3, pp. 155–164, 2003. View at Google Scholar
  34. S. Levicnik-Stezinar, U. Rahne-Potokar, D. Candotti, N. Lelie, and J. Allain, “Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients,” Journal of Hepatology, vol. 48, no. 6, pp. 1022–1025, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. H. Kao, “Diagnosis of hepatitis B virus infection through serological and virological markers,” Expert Review of Gastroenterology and Hepatology, vol. 2, no. 4, pp. 553–562, 2008. View at Publisher · View at Google Scholar
  36. Y.-Y. Zhang, B. G. Hansson, L. S. K. Kuo, A. Widell, and E. Nordenfelt, “Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg,” Hepatology, vol. 17, no. 4, pp. 538–544, 1993. View at Google Scholar · View at Scopus
  37. T. I. Michalak, C. Pasquinelli, S. Guilhot, and F. V. Chisari, “Hepatitis B virus persistence after recovery from acute viral hepatitis,” Journal of Clinical Investigation, vol. 93, no. 1, pp. 230–239, 1994. View at Google Scholar · View at Scopus
  38. B. Rehermann, C. Ferrari, C. Pasquinelli, and F. V. Chisari, “The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response,” Nature Medicine, vol. 2, no. 10, pp. 1104–1108, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Yotsuyanagi, K. Yasuda, S. Iino et al., “Persistent viremia after recovery from self-limited acute hepatitis B,” Hepatology, vol. 27, no. 5, pp. 1377–1382, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Yuki, T. Nagaoka, M. Yamashiro et al., “Long-term histologic and virologic outcomes of acute self-limited hepatitis B,” Hepatology, vol. 37, no. 5, pp. 1172–1179, 2003. View at Publisher · View at Google Scholar · View at Scopus